ObsEva SA to Participate in Upcoming Investor Conferences
April 01, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – April 1, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...